Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
User-agent: * Disallow: Crawl-delay: |
Title | Allakos │ Therapeutic antibodies │ Mast cells and |
Description | Allakos is developing therapeutic antibodies that selectively target eosinophils and mast cells, cells that play a significant role in many |
Keywords | N/A |
WebSite | allakos.com |
Host IP | 69.63.140.80 |
Location | United States |
Site | Rank |
US$32,879,390
Last updated: 2023-05-10 09:01:26
allakos.com has Semrush global rank of 321,913. allakos.com has an estimated worth of US$ 32,879,390, based on its estimated Ads revenue. allakos.com receives approximately 3,793,776 unique visitors each day. Its web server is located in United States, with IP address 69.63.140.80. According to SiteAdvisor, allakos.com is safe to visit. |
Purchase/Sale Value | US$32,879,390 |
Daily Ads Revenue | US$30,351 |
Monthly Ads Revenue | US$910,507 |
Yearly Ads Revenue | US$10,926,075 |
Daily Unique Visitors | 252,919 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
allakos.com. | A | 14399 | IP: 69.63.140.80 |
allakos.com. | NS | 3600 | NS Record: ns34.domaincontrol.com. |
allakos.com. | NS | 3600 | NS Record: ns33.domaincontrol.com. |
allakos.com. | MX | 3600 | MX Record: 0 allakos-com.mail.protection.outlook.com. |
allakos.com. | TXT | 3600 | TXT Record: docusign=899ed47f-5976-40e8-8e90-1f138ad904d5 |
allakos.com. | TXT | 3600 | TXT Record: adobe-idp-site-verification=ee3c55b0528626a918fb314886d99e5ee7612955835a28187df4369e1cbf4035 |
allakos.com. | TXT | 3600 | TXT Record: apple-domain-verification=VnEjL2m4KDNUHWju |
allakos.com. | TXT | 3600 | TXT Record: MS=ms48889298 |
allakos.com. | TXT | 3600 | TXT Record: docusign=bf966157-e1f6-4710-bc26-2da49e09905b |
allakos.com. | TXT | 3600 | TXT Record: ivdm84f266ohao15djmmdmse1s |
allakos.com. | TXT | 3600 | TXT Record: v=spf1 ip4:50.237.164.158 ip4:12.48.67.66 ip4:44.229.49.190 ip4:104.129.192.94 ip4:54.212.92.75 include:spf.protection.outlook.com include:email.freshservice.com include:emailus.freshservice.com include:prtg.com ~all |
Developing therapeutics which target immunomodulatory receptors present on immune effector cells involved in allergy, inflammatory and proliferative diseases Novel Biology developing therapeutic antibodies targeting Siglec receptors Lead Programs Focused on Inhibiting Mast Cell and/or Eosinophil Activation mast cells and eosinophils are pathogenic in a number of inflammatory diseases Lirentelimab (AK002) an investigational monoclonal antibody that depletes eosinophils and inhibits mast cells AK006 an investigational monoclonal antibody that selectively and potently inhibits mast cells, including KIT mediated signaling Multiple Indications within Inflammation & Immunology: Conducting Phase 2 studies in Chronic Spontaneous Urticaria and Atopic Dermatitis About Overview Management Board of Directors Scientific Advisors Science Overview Biology Lirentelimab (AK002) AK006 AK007 Scientific Presentations Clinical Overview Chronic Spontaneous Urticaria Atopic Dermatitis Patients Allakos |
HTTP/1.1 301 Moved Permanently Date: Tue, 02 Nov 2021 12:21:28 GMT Server: Apache Location: https://www.allakos.com/ Content-Type: text/html; charset=iso-8859-1 HTTP/1.1 200 OK Date: Tue, 02 Nov 2021 12:21:28 GMT Server: Apache Vary: User-Agent,Accept-Encoding Last-Modified: Tue, 26 Oct 2021 15:08:43 GMT Cache-Control: max-age=30, s-maxage=30 Expires: Tue, 02 Nov 2021 12:21:58 GMT X-Frame-Options: SAMEORIGIN X-Content-Type-Options: nosniff X-XSS-Protection: 1; mode=block Strict-Transport-Security-Test: max-age=60 Content-Security-Policy-Report-Only: default-src 'self' data:; report-uri /csp.cfm; style-src 'self' 'unsafe-inline' fonts.googleapis.com *.typekit.net; font-src 'self' data: https:; frame-ancestors 'self'; frame-src 'self' player.vimeo.com *.youtube.com www.google.com https://recruitingbypaycor.com; script-src 'self' 'unsafe-eval' 'unsafe-inline' ajax.googleapis.com www.google-analytics.com www.googletagmanager.com https://recruitingbypaycor.com https://newton.newtonsoftware.com; img-src 'self' data: www.google-analytics.com https://*.vimeocdn.com www.googletagmanager.com; connect-src 'self' www.google-analytics.com Content-Type: text/html;charset=UTF-8 |
Domain Name: ALLAKOS.COM Registry Domain ID: 1719008346_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2019-12-13T22:38:03Z Creation Date: 2012-05-08T21:12:27Z Registry Expiry Date: 2028-05-08T21:12:27Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS33.DOMAINCONTROL.COM Name Server: NS34.DOMAINCONTROL.COM DNSSEC: unsigned >>> Last update of whois database: 2021-09-20T19:58:52Z <<< |